First, ALstom and Mantra is advancing according to the agreement. Plain and simple, At this stage of the agreement there is no cause for Alstom to add addition revenue to Mantra. Status quo.
The two are advancing to start phase 4 which hopefully will lead to phase 5.
The two continue as originally planned to work together to obtain outside funding for phase 5. No distancing or separate, continuing as planned.
As far as toxic funding, NO BIG SURPRISE, this is a micro cap developmental stage company, it is going to happen. The surprising part is relativity speaking with how much they have accomplished how little it is. To be under a 100,000,000 shares after 7 years of operation, when never having any significant revenue stream is pretty darn good.
Compare it to other otc companies, example you like DNRG 171 million shares a 100 million more than MVTG. Lot of room there for toxic funding to reach that number of shares.
It is all relative.
News 
Market Data 
Discover 
